Thyroid stimulating hormone (TSH) is a glycoprotein hormone produced by the anterior pituitary gland, which stimulates the thyroid gland to produce thyroid hormones. Secretion is stimulated by thyroid-releasing hormone from the hypothalamus. Free thyroid hormones (FT4 and FT3) work in a negative feedback loop to regulate the amount of TSH that is released from the pituitary gland. Dysregulation of TSH may either be a primary or secondary condition causing either hypo- or hyperthyroidism. Although thyroid issues are seen at all ages, onset is usually seen in the late 40s or early 50s, and affects females almost four times more often than males. An elevated TSH result usually means an underactive thyroid (hypothyroidism), whereas a decreased result means an overactive thyroid gland (hyperthyroidism) or excessive amounts of thyroid medication in an individual being treated for hypothyroidism. Measurement of serum TSH is the best initial laboratory test of thyroid function. If TSH levels are abnormal, free thyroxine (FT3) should then be measured. Also, measurement of anti-thyroperoxidase antibody should be done if the TSH level is high.
| uU/mL | mU/L | |
| Premature infants | ||
| (28-36 wk gestation): | 0.7-27 | 0.7-27 |
| 1-4 days: | 1.0-39 | 1.0-39 |
| 2-20 wk: | 1.7-9.1 | 1.7-9.1 |
| 5 mo-20 yr: | 0.7-6.4 | 0.7-6.4 |
| Adults | ||
| 21-54 yr: | 0.4-4.2 | 0.4-4.2 |
| 55-87 yr: | 0.5-8.9 | 0.5-8.9 |
| Pregnancy | ||
| First trimester: | 0.3-4.5 | 0.3-4.5 |
| Second trimester: | 0.5-4.6 | 0.5-4.6 |
| Third trimester: | 0.8-5.2 | 0.8-5.2 |
Immunoassay.
Free Thyroxine (Free T4), Total Thyroxine (T4 total), Thyroid stimulating immunoglobulin, Thyroid peroxidase antibody (TPO antibody), Thyroid Stimulating Hormone Receptor Antibody, Thyroglobulin Antibody.
1-3 days.
| 84443 |
| A51.32 | Syphilitic alopecia |
| B02.23 | Postherpetic polyneuropathy |
| B17.1 | Acute hepatitis C |
| B18.2 | Chronic viral hepatitis C |
| B19.2 | Unspecified viral hepatitis C |
| B19.20 | Unspecified viral hepatitis C without hepatic coma |
| B19.21 | Unspecified viral hepatitis C with hepatic coma |
| C15 | Malignant neoplasm of esophagus |
| C16 | Malignant neoplasm of stomach |
| C17 | Malignant neoplasm of small intestine |
| C17.0 | Malignant neoplasm of duodenum |
| C17.1 | Malignant neoplasm of jejunum |
| C17.2 | Malignant neoplasm of ileum |
| C18 | Malignant neoplasm of colon |
| C19 | Malignant neoplasm of rectosigmoid junction |
| C20 | Malignant neoplasm of rectum |
| C25 | Malignant neoplasm of pancreas |
| C25.4 | Malignant neoplasm of endocrine pancreas |
| C25.9 | Malignant neoplasm of pancreas, unspecified |
| C58 | Malignant neoplasm of placenta |
| C65 | Malignant neoplasm of renal pelvis |
| C65.1 | Malignant neoplasm of right renal pelvis |
| C65.2 | Malignant neoplasm of left renal pelvis |
| C65.9 | Malignant neoplasm of unspecified renal pelvis |
| C73 | Malignant neoplasm of thyroid gland |
| C75.1 | Malignant neoplasm of pituitary gland |
| D13 | Benign neoplasm of other and ill-defined parts of digestive system |
| D13.1 | Benign neoplasm of stomach |
| D13.6 | Benign neoplasm of pancreas |
| D13.7 | Benign neoplasm of endocrine pancreas |
| D27.9 | Benign neoplasm of unspecified ovary |
| D34 | Benign neoplasm of thyroid gland |
| D35 | Benign neoplasm of other and unspecified endocrine glands |
| D35.2 | Benign neoplasm of pituitary gland |
| D3A | Benign neuroendocrine tumors |
| D3A.8 | Other benign neuroendocrine tumors |
| D46 | Myelodysplastic syndromes |
| D46.9 | Myelodysplastic syndrome, unspecified |
| D46.Z | Other myelodysplastic syndromes |
| D55 | Anemia due to enzyme disorders |
| D55.1 | Anemia due to other disorders of glutathione metabolism |
| D62 | Acute posthemorrhagic anemia |
| D63 | Anemia in chronic diseases classified elsewhere |
| D63.0 | Anemia in neoplastic disease |
| D63.1 | Anemia in chronic kidney disease |
| D63.8 | Anemia in other chronic diseases classified elsewhere |
| D64 | Other anemias |
| D64.9 | Anemia, unspecified |
| D69.3 | Immune thrombocytopenic purpura |
| D69.4 | Other primary thrombocytopenia |
| D80.1 | Nonfamilial hypogammaglobulinemia |
| D82 | Immunodeficiency associated with other major defects |
| D82.1 | Di George's syndrome |
| D84.1 | Defects in the complement system |
| E00 | Congenital iodine-deficiency syndrome |
| E00.9 | Congenital iodine-deficiency syndrome, unspecified |
| E01.0 | Iodine-deficiency related diffuse (endemic) goiter |
| E02 | Subclinical iodine-deficiency hypothyroidism |
| E03 | Other hypothyroidism |
| E03.0 | Congenital hypothyroidism with diffuse goiter |
| E03.1 | Congenital hypothyroidism without goiter |
| E03.2 | Hypothyroidism due to medicaments and other exogenous substances |
| E03.3 | Postinfectious hypothyroidism |
| E03.8 | Other specified hypothyroidism |
| E03.9 | Hypothyroidism, unspecified |
| E04 | Other nontoxic goiter |
| E04.1 | Nontoxic single thyroid nodule |
| E04.2 | Nontoxic multinodular goiter |
| E04.9 | Nontoxic goiter, unspecified |
| E05 | Thyrotoxicosis [hyperthyroidism] |
| E05.0 | Thyrotoxicosis with diffuse goiter |
| E05.00 | Thyrotoxicosis with diffuse goiter without thyrotoxic crisis or storm |
| E05.01 | Thyrotoxicosis with diffuse goiter with thyrotoxic crisis or storm |
| E05.1 | Thyrotoxicosis with toxic single thyroid nodule |
| E05.2 | Thyrotoxicosis with toxic multinodular goiter |
| E05.8 | Other thyrotoxicosis |
| E05.9 | Thyrotoxicosis, unspecified |
| E06 | Thyroiditis |
| E06.0 | Acute thyroiditis |
| E06.1 | Subacute thyroiditis |
| E06.2 | Chronic thyroiditis with transient thyrotoxicosis |
| E06.3 | Autoimmune thyroiditis |
| E06.4 | Drug-induced thyroiditis |
| E06.5 | Other chronic thyroiditis |
| E06.9 | Thyroiditis, unspecified |
| E07 | Other disorders of thyroid |
| E07.1 | Dyshormogenetic goiter |
| E07.9 | Disorder of thyroid, unspecified |
| E08 | Diabetes mellitus due to underlying condition |
| E08.8 | Diabetes mellitus due to underlying condition with unspecified complications |
| E08.9 | Diabetes mellitus due to underlying condition without complications |
| E10 | Type 1 diabetes mellitus |
| E10.1 | Type 1 diabetes mellitus with ketoacidosis |
| E10.8 | Type 1 diabetes mellitus with unspecified complications |
| E10.9 | Type 1 diabetes mellitus without complications |
| E11 | Type 2 diabetes mellitus |
| E11.69 | Type 2 diabetes mellitus with other specified complication |
| E11.8 | Type 2 diabetes mellitus with unspecified complications |
| E11.9 | Type 2 diabetes mellitus without complications |
| E13 | Other specified diabetes mellitus |
| E13.9 | Other specified diabetes mellitus without complications |
| E16.1 | Other hypoglycemia |
| E16.2 | Hypoglycemia, unspecified |
| E20 | Hypoparathyroidism |
| E20.0 | Idiopathic hypoparathyroidism |
| E20.8 | Other hypoparathyroidism |
| E20.9 | Hypoparathyroidism, unspecified |
| E21.0 | Primary hyperparathyroidism |
| E21.1 | Secondary hyperparathyroidism, not elsewhere classified |
| E21.2 | Other hyperparathyroidism |
| E21.3 | Hyperparathyroidism, unspecified |
| E22 | Hyperfunction of pituitary gland |
| E22.0 | Acromegaly and pituitary gigantism |
| E22.1 | Hyperprolactinemia |
| E22.2 | Syndrome of inappropriate secretion of antidiuretic hormone |
| E22.8 | Other hyperfunction of pituitary gland |
| E22.9 | Hyperfunction of pituitary gland, unspecified |
| E23 | Hypofunction and other disorders of the pituitary gland |
| E23.0 | Hypopituitarism |
| E23.1 | Drug-induced hypopituitarism |
| E23.2 | Diabetes insipidus |
| E23.3 | Hypothalamic dysfunction, not elsewhere classified |
| E23.6 | Other disorders of pituitary gland |
| E23.7 | Disorder of pituitary gland, unspecified |
| E25 | Adrenogenital disorders |
| E25.0 | Congenital adrenogenital disorders associated with enzyme deficiency |
| E25.8 | Other adrenogenital disorders |
| E25.9 | Adrenogenital disorder, unspecified |
| E26 | Hyperaldosteronism |
| E26.1 | Secondary hyperaldosteronism |
| E26.8 | Other hyperaldosteronism |
| E26.9 | Hyperaldosteronism, unspecified |
| E27 | Other disorders of adrenal gland |
| E27.1 | Primary adrenocortical insufficiency |
| E27.2 | Addisonian crisis |
| E27.3 | Drug-induced adrenocortical insufficiency |
| E27.4 | Other and unspecified adrenocortical insufficiency |
| E27.40 | Unspecified adrenocortical insufficiency |
| E27.49 | Other adrenocortical insufficiency |
| E27.9 | Disorder of adrenal gland, unspecified |
| E28 | Ovarian dysfunction |
| E28.2 | Polycystic ovarian syndrome |
| E28.3 | Primary ovarian failure |
| E28.31 | Premature menopause |
| E28.310 | Symptomatic premature menopause |
| E28.39 | Other primary ovarian failure |
| E28.8 | Other ovarian dysfunction |
| E28.9 | Ovarian dysfunction, unspecified |
| E29 | Testicular dysfunction |
| E29.1 | Testicular hypofunction |
| E29.8 | Other testicular dysfunction |
| E29.9 | Testicular dysfunction, unspecified |
| E31.2 | Multiple endocrine neoplasia [MEN] syndromes |
| E31.20 | Multiple endocrine neoplasia [MEN] syndrome, unspecified |
| E31.21 | Multiple endocrine neoplasia [MEN] type I |
| E31.22 | Multiple endocrine neoplasia [MEN] type IIA |
| E31.23 | Multiple endocrine neoplasia [MEN] type IIB |
| E34 | Other endocrine disorders |
| E34.2 | Ectopic hormone secretion, not elsewhere classified |
| E34.3 | Short stature due to endocrine disorder |
| E34.4 | Constitutional tall stature |
| E34.9 | Endocrine disorder, unspecified |
| E44 | Protein-calorie malnutrition of moderate and mild degree |
| E44.0 | Moderate protein-calorie malnutrition |
| E44.1 | Mild protein-calorie malnutrition |
| E61 | Deficiency of other nutrient elements |
| E65 | Localized adiposity |
| E66 | Overweight and obesity |
| E66.0 | Obesity due to excess calories |
| E66.09 | Other obesity due to excess calories |
| E66.3 | Overweight |
| E66.8 | Other obesity |
| E66.9 | Obesity, unspecified |
| E70 | Disorders of aromatic amino-acid metabolism |
| E72 | Other disorders of amino-acid metabolism |
| E72.12 | Methylenetetrahydrofolate reductase deficiency |
| E72.9 | Disorder of amino-acid metabolism, unspecified |
| E74.8 | Other specified disorders of carbohydrate metabolism |
| E78 | Disorders of lipoprotein metabolism and other lipidemias |
| E78.0 | Pure hypercholesterolemia |
| E78.1 | Pure hyperglyceridemia |
| E78.2 | Mixed hyperlipidemia |
| E78.4 | Other hyperlipidemia |
| E78.5 | Hyperlipidemia, unspecified |
| E78.6 | Lipoprotein deficiency |
| E78.9 | Disorder of lipoprotein metabolism, unspecified |
| E79 | Disorders of purine and pyrimidine metabolism |
| E79.0 | Hyperuricemia without signs of inflammatory arthritis and tophaceous disease |
| E79.1 | Lesch-Nyhan syndrome |
| E79.8 | Other disorders of purine and pyrimidine metabolism |
| E79.9 | Disorder of purine and pyrimidine metabolism, unspecified |
| E83 | Disorders of mineral metabolism |
| E83.00 | Disorder of copper metabolism, unspecified |
| E83.01 | Wilson's disease |
| E83.39 | Other disorders of phosphorus metabolism |
| E83.41 | Hypermagnesemia |
| E83.42 | Hypomagnesemia |
| E83.49 | Other disorders of magnesium metabolism |
| E83.5 | Disorders of calcium metabolism |
| E83.52 | Hypercalcemia |
| E83.59 | Other disorders of calcium metabolism |
| E87 | Other disorders of fluid, electrolyte and acid-base balance |
| E87.0 | Hyperosmolality and hypernatremia |
| E87.1 | Hypo-osmolality and hyponatremia |
| E87.2 | Acidosis |
| E87.3 | Alkalosis |
| E87.4 | Mixed disorder of acid-base balance |
| E88 | Other and unspecified metabolic disorders |
| E88.81 | Metabolic syndrome |
| E88.9 | Metabolic disorder, unspecified |
| E89.0 | Postprocedural hypothyroidism |
| E89.2 | Postprocedural hypoparathyroidism |
| E89.4 | Postprocedural ovarian failure |
| F01 | Vascular dementia |
| F02 | Dementia in other diseases classified elsewhere |
| F03 | Unspecified dementia |
| F03.90 | Unspecified dementia without behavioral disturbance |
| F03.91 | Unspecified dementia with behavioral disturbance |
| F06 | Other mental disorders due to known physiological condition |
| F06.4 | Anxiety disorder due to known physiological condition |
| F10.1 | Alcohol abuse |
| F10.27 | Alcohol dependence with alcohol-induced persisting dementia |
| F12.25 | Cannabis dependence with psychotic disorder |
| F16.20 | Hallucinogen dependence, uncomplicated |
| F18.17 | Inhalant abuse with inhalant-induced dementia |
| F20 | Schizophrenia |
| F20.0 | Paranoid schizophrenia |
| F20.1 | Disorganized schizophrenia |
| F20.2 | Catatonic schizophrenia |
| F20.3 | Undifferentiated schizophrenia |
| F20.5 | Residual schizophrenia |
| F20.8 | Other schizophrenia |
| F20.81 | Schizophreniform disorder |
| F20.89 | Other schizophrenia |
| F20.9 | Schizophrenia, unspecified |
| F22 | Delusional disorders |
| F23 | Brief psychotic disorder |
| F25.0 | Schizoaffective disorder, bipolar type |
| F25.1 | Schizoaffective disorder, depressive type |
| F28 | Other psychotic disorder not due to a substance or known physiological condition |
| F29 | Unspecified psychosis not due to a substance or known physiological condition |
| F30.10 | Manic episode without psychotic symptoms, unspecified |
| F31 | Bipolar disorder |
| F31.8 | Other bipolar disorders |
| F31.81 | Bipolar II disorder |
| F31.89 | Other bipolar disorder |
| F31.9 | Bipolar disorder, unspecified |
| F32 | Major depressive disorder, single episode |
| F32.0 | Major depressive disorder, single episode, mild |
| F32.1 | Major depressive disorder, single episode, moderate |
| F32.2 | Major depressive disorder, single episode, severe without psychotic features |
| F32.3 | Major depressive disorder, single episode, severe with psychotic features |
| F32.4 | Major depressive disorder, single episode, in partial remission |
| F32.5 | Major depressive disorder, single episode, in full remission |
| F32.8 | Other depressive episodes |
| F32.9 | Major depressive disorder, single episode, unspecified |
| F33 | Major depressive disorder, recurrent |
| F33.1 | Major depressive disorder, recurrent, moderate |
| F33.2 | Major depressive disorder, recurrent severe without psychotic features |
| F33.8 | Other recurrent depressive disorders |
| F34.1 | Dysthymic disorder |
| F39 | Unspecified mood [affective] disorder |
| F40 | Phobic anxiety disorders |
| F40.0 | Agoraphobia |
| F40.240 | Claustrophobia |
| F41 | Other anxiety disorders |
| F41.1 | Generalized anxiety disorder |
| F41.3 | Other mixed anxiety disorders |
| F41.9 | Anxiety disorder, unspecified |
| F42 | Obsessive-compulsive disorder |
| F43.0 | Acute stress reaction |
| F44.5 | Conversion disorder with seizures or convulsions |
| F60.8 | Other specific personality disorders |
| F90 | Attention-deficit hyperactivity disorders |
| F90.1 | Attention-deficit hyperactivity disorder, predominantly hyperactive type |
| F90.2 | Attention-deficit hyperactivity disorder, combined type |
| F90.8 | Attention-deficit hyperactivity disorder, other type |
| F90.9 | Attention-deficit hyperactivity disorder, unspecified type |
| F95 | Tic disorder |
| F95.2 | Tourette's disorder |
| F98 | Other behavioral and emotional disorders with onset usually occurring in childhood and adolescence |
| F99 | Mental disorder, not otherwise specified |
| G04.81 | Other encephalitis and encephalomyelitis |
| G10 | Huntington's disease |
| G11 | Hereditary ataxia |
| G11.3 | Cerebellar ataxia with defective DNA repair |
| G11.8 | Other hereditary ataxias |
| G11.9 | Hereditary ataxia, unspecified |
| G12.2 | Motor neuron disease |
| G12.20 | Motor neuron disease, unspecified |
| G12.21 | Amyotrophic lateral sclerosis |
| G20 | Parkinson's disease |
| G21 | Secondary parkinsonism |
| G24.5 | Blepharospasm |
| G25.81 | Restless legs syndrome |
| G30.0 | Alzheimer's disease with early onset |
| G30.1 | Alzheimer's disease with late onset |
| G30.8 | Other Alzheimer's disease |
| G30.9 | Alzheimer's disease, unspecified |
| G31.84 | Mild cognitive impairment, so stated |
| G35 | Multiple sclerosis |
| G40 | Epilepsy and recurrent seizures |
| G40.1 | Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures |
| G40.89 | Other seizures |
| G40.9 | Epilepsy, unspecified |
| G47 | Sleep disorders |
| G47.0 | Insomnia |
| G47.00 | Insomnia, unspecified |
| G47.09 | Other insomnia |
| G47.3 | Sleep apnea |
| G47.30 | Sleep apnea, unspecified |
| G47.31 | Primary central sleep apnea |
| G47.33 | Obstructive sleep apnea (adult) (pediatric) |
| G58.9 | Mononeuropathy, unspecified |
| G60 | Hereditary and idiopathic neuropathy |
| G60.0 | Hereditary motor and sensory neuropathy |
| G60.3 | Idiopathic progressive neuropathy |
| G60.8 | Other hereditary and idiopathic neuropathies |
| G61 | Inflammatory polyneuropathy |
| G61.1 | Serum neuropathy |
| G62 | Other and unspecified polyneuropathies |
| G62.9 | Polyneuropathy, unspecified |
| G63 | Polyneuropathy in diseases classified elsewhere |
| G70.0 | Myasthenia gravis |
| G70.00 | Myasthenia gravis without (acute) exacerbation |
| G73 | Disorders of myoneural junction and muscle in diseases classified elsewhere |
| G73.7 | Myopathy in diseases classified elsewhere |
| G90.0 | Idiopathic peripheral autonomic neuropathy |
| G92 | Toxic encephalopathy |
| G93.40 | Encephalopathy, unspecified |
| G99 | Other disorders of nervous system in diseases classified elsewhere |
| G99.0 | Autonomic neuropathy in diseases classified elsewhere |
| I10 | Essential (primary) hypertension |
| I11.0 | Hypertensive heart disease with heart failure |
| I15 | Secondary hypertension |
| I15.2 | Hypertension secondary to endocrine disorders |
| I15.8 | Other secondary hypertension |
| I15.9 | Secondary hypertension, unspecified |
| I27.0 | Primary pulmonary hypertension |
| I27.2 | Other secondary pulmonary hypertension |
| I28.9 | Disease of pulmonary vessels, unspecified |
| I35 | Nonrheumatic aortic valve disorders |
| I42 | Cardiomyopathy |
| I42.0 | Dilated cardiomyopathy |
| I42.1 | Obstructive hypertrophic cardiomyopathy |
| I42.2 | Other hypertrophic cardiomyopathy |
| I42.5 | Other restrictive cardiomyopathy |
| I42.8 | Other cardiomyopathies |
| I42.9 | Cardiomyopathy, unspecified |
| I46 | Cardiac arrest |
| I46.2 | Cardiac arrest due to underlying cardiac condition |
| I46.8 | Cardiac arrest due to other underlying condition |
| I46.9 | Cardiac arrest, cause unspecified |
| I48 | Atrial fibrillation and flutter |
| I48.0 | Paroxysmal atrial fibrillation |
| I48.1 | Persistent atrial fibrillation |
| I48.2 | Chronic atrial fibrillation |
| I48.9 | Unspecified atrial fibrillation and atrial flutter |
| I48.91 | Unspecified atrial fibrillation |
| I49 | Other cardiac arrhythmias |
| I49.8 | Other specified cardiac arrhythmias |
| I49.9 | Cardiac arrhythmia, unspecified |
| I50 | Heart failure |
| I50.20 | Unspecified systolic (congestive) heart failure |
| I50.21 | Acute systolic (congestive) heart failure |
| I50.22 | Chronic systolic (congestive) heart failure |
| I50.23 | Acute on chronic systolic (congestive) heart failure |
| I50.30 | Unspecified diastolic (congestive) heart failure |
| I50.31 | Acute diastolic (congestive) heart failure |
| I50.32 | Chronic diastolic (congestive) heart failure |
| I50.33 | Acute on chronic diastolic (congestive) heart failure |
| I50.40 | Unspecified combined systolic (congestive) and diastolic (congestive) heart failure |
| I50.41 | Acute combined systolic (congestive) and diastolic (congestive) heart failure |
| I50.42 | Chronic combined systolic (congestive) and diastolic (congestive) heart failure |
| I50.43 | Acute on chronic combined systolic (congestive) and diastolic (congestive) heart failure |
| I50.9 | Heart failure, unspecified |
| I51.7 | Cardiomegaly |
| I73.0 | Raynaud's syndrome |
| I73.00 | Raynaud's syndrome without gangrene |
| I73.01 | Raynaud's syndrome with gangrene |
| I87.39 | Chronic venous hypertension (idiopathic) with other complications |
| I89.0 | Lymphedema, not elsewhere classified |
| I95.0 | Idiopathic hypotension |
| I97.2 | Postmastectomy lymphedema syndrome |
| I99 | Other and unspecified disorders of circulatory system |
| J40 | Bronchitis, not specified as acute or chronic |
| J41.0 | Simple chronic bronchitis |
| J43 | Emphysema |
| J44 | Other chronic obstructive pulmonary disease |
| J44.0 | Chronic obstructive pulmonary disease with (acute) lower respiratory infection |
| J44.1 | Chronic obstructive pulmonary disease with (acute) exacerbation |
| J44.9 | Chronic obstructive pulmonary disease, unspecified |
| J45 | Asthma |
| J47 | Bronchiectasis |
| J99 | Respiratory disorders in diseases classified elsewhere |
| K29.3 | Chronic superficial gastritis |
| K29.4 | Chronic atrophic gastritis |
| K29.40 | Chronic atrophic gastritis without bleeding |
| K29.41 | Chronic atrophic gastritis with bleeding |
| K29.5 | Unspecified chronic gastritis |
| K29.6 | Other gastritis |
| K29.7 | Gastritis, unspecified |
| K52 | Other and unspecified noninfective gastroenteritis and colitis |
| K70 | Alcoholic liver disease |
| K70.0 | Alcoholic fatty liver |
| K70.1 | Alcoholic hepatitis |
| K76.0 | Fatty (change of) liver, not elsewhere classified |
| K76.9 | Liver disease, unspecified |
| K90 | Intestinal malabsorption |
| K90.8 | Other intestinal malabsorption |
| K90.81 | Whipple's disease |
| K90.89 | Other intestinal malabsorption |
| K90.9 | Intestinal malabsorption, unspecified |
| K91.2 | Postsurgical malabsorption, not elsewhere classified |
| L29 | Pruritus |
| L29.0 | Pruritus ani |
| L29.1 | Pruritus scroti |
| L29.2 | Pruritus vulvae |
| L29.3 | Anogenital pruritus, unspecified |
| L29.8 | Other pruritus |
| L29.9 | Pruritus, unspecified |
| L50 | Urticaria |
| L50.0 | Allergic urticaria |
| L50.1 | Idiopathic urticaria |
| L50.6 | Contact urticaria |
| L50.8 | Other urticaria |
| L50.9 | Urticaria, unspecified |
| L63 | Alopecia areata |
| L63.0 | Alopecia (capitis) totalis |
| L63.1 | Alopecia universalis |
| L63.8 | Other alopecia areata |
| L63.9 | Alopecia areata, unspecified |
| L64 | Androgenic alopecia |
| L64.0 | Drug-induced androgenic alopecia |
| L64.8 | Other androgenic alopecia |
| L64.9 | Androgenic alopecia, unspecified |
| L65 | Other nonscarring hair loss |
| L65.2 | Alopecia mucinosa |
| L66 | Cicatricial alopecia [scarring hair loss] |
| L66.8 | Other cicatricial alopecia |
| L66.9 | Cicatricial alopecia, unspecified |
| L68.0 | Hirsutism |
| L83 | Acanthosis nigricans |
| M31.5 | Giant cell arteritis with polymyalgia rheumatica |
| M33 | Dermatopolymyositis |
| M33.0 | Juvenile dermatomyositis |
| M33.1 | Other dermatomyositis |
| M33.9 | Dermatopolymyositis, unspecified |
| M35.00 | Sicca syndrome, unspecified |
| M35.3 | Polymyalgia rheumatica |
| M60 | Myositis |
| M60.0 | Infective myositis |
| M60.00 | Infective myositis, unspecified site |
| M60.8 | Other myositis |
| M60.80 | Other myositis, unspecified site |
| M60.9 | Myositis, unspecified |
| M62.81 | Muscle weakness (generalized) |
| M62.83 | Muscle spasm |
| M62.830 | Muscle spasm of back |
| M79.1 | Myalgia |
| M79.7 | Fibromyalgia |
| M80.0 | Age-related osteoporosis with current pathological fracture |
| M81 | Osteoporosis without current pathological fracture |
| M85 | Other disorders of bone density and structure |
| M87 | Osteonecrosis |
| M87.10 | Osteonecrosis due to drugs, unspecified bone |
| M87.20 | Osteonecrosis due to previous trauma, unspecified bone |
| M87.30 | Other secondary osteonecrosis, unspecified bone |
| M87.8 | Other osteonecrosis |
| M87.80 | Other osteonecrosis, unspecified bone |
| M87.9 | Osteonecrosis, unspecified |
| M89 | Other disorders of bone |
| M90.50 | Osteonecrosis in diseases classified elsewhere, unspecified site |
| N11.1 | Chronic obstructive pyelonephritis |
| N16 | Renal tubulo-interstitial disorders in diseases classified elsewhere |
| N20 | Calculus of kidney and ureter |
| N20.0 | Calculus of kidney |
| N20.1 | Calculus of ureter |
| N20.2 | Calculus of kidney with calculus of ureter |
| N20.9 | Urinary calculus, unspecified |
| N21 | Calculus of lower urinary tract |
| N46 | Male infertility |
| N46.9 | Male infertility, unspecified |
| N48.3 | Priapism |
| N48.30 | Priapism, unspecified |
| N48.31 | Priapism due to trauma |
| N48.32 | Priapism due to disease classified elsewhere |
| N48.33 | Priapism, drug-induced |
| N48.39 | Other priapism |
| N62 | Hypertrophy of breast |
| N64.3 | Galactorrhea not associated with childbirth |
| N64.9 | Disorder of breast, unspecified |
| N83.20 | Unspecified ovarian cysts |
| N91.0 | Primary amenorrhea |
| N91.1 | Secondary amenorrhea |
| N91.2 | Amenorrhea, unspecified |
| N92 | Excessive, frequent and irregular menstruation |
| N93 | Other abnormal uterine and vaginal bleeding |
| N93.8 | Other specified abnormal uterine and vaginal bleeding |
| N93.9 | Abnormal uterine and vaginal bleeding, unspecified |
| N95 | Menopausal and other perimenopausal disorders |
| N95.0 | Postmenopausal bleeding |
| N95.1 | Menopausal and female climacteric states |
| N95.2 | Postmenopausal atrophic vaginitis |
| N95.8 | Other specified menopausal and perimenopausal disorders |
| N95.9 | Unspecified menopausal and perimenopausal disorder |
| N96 | Recurrent pregnancy loss |
| N97 | Female infertility |
| N97.9 | Female infertility, unspecified |
| O01 | Hydatidiform mole |
| O02 | Other abnormal products of conception |
| O03 | Spontaneous abortion |
| O03.2 | Embolism following incomplete spontaneous abortion |
| O03.30 | Unspecified complication following incomplete spontaneous abortion |
| O03.37 | Sepsis following incomplete spontaneous abortion |
| O03.38 | Urinary tract infection following incomplete spontaneous abortion |
| O03.4 | Incomplete spontaneous abortion without complication |
| O04 | Complications following (induced) termination of pregnancy |
| O04.87 | Sepsis following (induced) termination of pregnancy |
| O04.89 | (Induced) termination of pregnancy with other complications |
| O09 | Supervision of high risk pregnancy |
| O09.0 | Supervision of pregnancy with history of infertility |
| O09.3 | Supervision of pregnancy with insufficient antenatal care |
| O24.02 | Pre-existing type 1 diabetes mellitus, in childbirth |
| O24.1 | Pre-existing type 2 diabetes mellitus, in pregnancy, childbirth and the puerperium |
| O24.4 | Gestational diabetes mellitus |
| O24.41 | Gestational diabetes mellitus in pregnancy |
| O26 | Maternal care for other conditions predominantly related to pregnancy |
| O28 | Abnormal findings on antenatal screening of mother |
| O28.9 | Unspecified abnormal findings on antenatal screening of mother |
| O36.01 | Maternal care for anti-D [Rh] antibodies |
| O90.5 | Postpartum thyroiditis |
| O92.6 | Galactorrhea |
| O99.01 | Anemia complicating pregnancy |
| O99.280 | Endocrine, nutritional and metabolic diseases complicating pregnancy, unspecified trimester |
| P58 | Neonatal jaundice due to other excessive hemolysis |
| P59.0 | Neonatal jaundice associated with preterm delivery |
| P59.9 | Neonatal jaundice, unspecified |
| P70.4 | Other neonatal hypoglycemia |
| Q24.9 | Congenital malformation of heart, unspecified |
| Q38.2 | Macroglossia |
| Q78.2 | Osteopetrosis |
| Q79.2 | Exomphalos |
| Q82 | Other congenital malformations of skin |
| Q82.0 | Hereditary lymphedema |
| Q82.8 | Other specified congenital malformations of skin |
| Q82.9 | Congenital malformation of skin, unspecified |
| Q84.0 | Congenital alopecia |
| Q87 | Other specified congenital malformation syndromes affecting multiple systems |
| Q87.1 | Congenital malformation syndromes predominantly associated with short stature |
| Q87.3 | Congenital malformation syndromes involving early overgrowth |
| Q87.8 | Other specified congenital malformation syndromes, not elsewhere classified |
| Q93 | Monosomies and deletions from the autosomes, not elsewhere classified |
| Q93.8 | Other deletions from the autosomes |
| Q93.88 | Other microdeletions |
| Q93.89 | Other deletions from the autosomes |
| Q96 | Turner's syndrome |
| Q96.8 | Other variants of Turner's syndrome |
| Q96.9 | Turner's syndrome, unspecified |
| Q98.0 | Klinefelter syndrome karyotype 47, XXY |
| Q98.1 | Klinefelter syndrome, male with more than two X chromosomes |
| Q98.4 | Klinefelter syndrome, unspecified |
| R00 | Abnormalities of heart beat |
| R01 | Cardiac murmurs and other cardiac sounds |
| R03 | Abnormal blood-pressure reading, without diagnosis |
| R17 | Unspecified jaundice |
| R40.2 | Coma |
| R40.20 | Unspecified coma |
| R41 | Other symptoms and signs involving cognitive functions and awareness |
| R43.0 | Anosmia |
| R53 | Malaise and fatigue |
| R53.82 | Chronic fatigue, unspecified |
| R54 | Age-related physical debility |
| R56 | Convulsions, not elsewhere classified |
| R56.1 | Post traumatic seizures |
| R63.0 | Anorexia |
| R63.4 | Abnormal weight loss |
| R71 | Abnormality of red blood cells |
| R73 | Elevated blood glucose level |
| R94.6 | Abnormal results of thyroid function studies |
| S06.9X0 | Unspecified intracranial injury without loss of consciousness |
| T78.3 | Angioneurotic edema |
| Z00 | Encounter for general examination without complaint, suspected or reported diagnosis |
| Z00.0 | Encounter for general adult medical examination |
| Z00.00 | Encounter for general adult medical examination without abnormal findings |
| Z00.01 | Encounter for general adult medical examination with abnormal findings |
| Z00.8 | Encounter for other general examination |
| Z01.41 | Encounter for routine gynecological examination |
| Z01.411 | Encounter for gynecological examination (general) (routine) with abnormal findings |
| Z01.83 | Encounter for blood typing |
| Z01.84 | Encounter for antibody response examination |
| Z12.10 | Encounter for screening for malignant neoplasm of intestinal tract, unspecified |
| Z12.73 | Encounter for screening for malignant neoplasm of ovary |
| Z13.1 | Encounter for screening for diabetes mellitus |
| Z13.21 | Encounter for screening for nutritional disorder |
| Z13.22 | Encounter for screening for metabolic disorder |
| Z13.220 | Encounter for screening for lipoid disorders |
| Z13.228 | Encounter for screening for other metabolic disorders |
| Z13.6 | Encounter for screening for cardiovascular disorders |
| Z13.7 | Encounter for screening for genetic and chromosomal anomalies |
| Z13.820 | Encounter for screening for osteoporosis |
| Z15.02 | Genetic susceptibility to malignant neoplasm of ovary |
| Z20 | Contact with and (suspected) exposure to communicable diseases |
| Z20.5 | Contact with and (suspected) exposure to viral hepatitis |
| Z30.014 | Encounter for initial prescription of intrauterine contraceptive device |
| Z30.8 | Encounter for other contraceptive management |
| Z31.441 | Encounter for testing of male partner of patient with recurrent pregnancy loss |
| Z31.81 | Encounter for male factor infertility in female patient |
| Z32.0 | Encounter for pregnancy test |
| Z34 | Encounter for supervision of normal pregnancy |
| Z34.8 | Encounter for supervision of other normal pregnancy |
| Z34.9 | Encounter for supervision of normal pregnancy, unspecified |
| Z34.90 | Encounter for supervision of normal pregnancy, unspecified, unspecified trimester |
| Z36 | Encounter for antenatal screening of mother |
| Z67 | Blood type |
| Z68 | Body mass index [BMI] |
| Z77 | Other contact with and (suspected) exposures hazardous to health |
| Z77.120 | Contact with and (suspected) exposure to mold (toxic) |
| Z78.0 | Asymptomatic menopausal state |
| Z80.41 | Family history of malignant neoplasm of ovary |
| Z82.0 | Family history of epilepsy and other diseases of the nervous system |
| Z83.3 | Family history of diabetes mellitus |
| Z83.49 | Family history of other endocrine, nutritional and metabolic diseases |
| Z84 | Family history of other conditions |
| Z85 | Personal history of malignant neoplasm |
| Z85.43 | Personal history of malignant neoplasm of ovary |
| Z85.53 | Personal history of malignant neoplasm of renal pelvis |
| Z85.85 | Personal history of malignant neoplasm of endocrine glands |
| Z85.850 | Personal history of malignant neoplasm of thyroid |
| Z86.59 | Personal history of other mental and behavioral disorders |